EPO and neoplasm: Furthermore, systemic treatment of EPO increased infiltration of CD11b+ macrophages in tumor-draining lymph nodes and also increased VEGF-C expression in lymph-node-derived CD11b+ macrophages as well as in bone-marrow-derived macrophages in a dose- and time-dependent manner.